Home Cart Sign in  
Chemical Structure| 956958-53-5 Chemical Structure| 956958-53-5

Structure of Pilaralisib analogue
CAS No.: 956958-53-5

Chemical Structure| 956958-53-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

XL147 analogue is a selective and reversible class I PI3K inhibitor for PI3Kα/δ/γ with IC50 of 39 nM/36 nM/23 nM in cell-free assays, less potent to PI3Kβ.

Synonyms: XL147 Analogue; XL147 analog; XL147 derivative II

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Pilaralisib analogue

CAS No. :956958-53-5
Formula : C21H16N6O2S2
M.W : 448.52
SMILES Code : O=S(NC1=NC2=C(C=CC=C2)N=C1NC3=CC4=NSN=C4C=C3)(C5=CC=C(C=C5)C)=O
Synonyms :
XL147 Analogue; XL147 analog; XL147 derivative II
MDL No. :MFCD16621245
InChI Key :MQMKRQLTIWPEDM-UHFFFAOYSA-N
Pubchem ID :1893730

Safety of Pilaralisib analogue

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Pilaralisib analogue

PI3K-AKT

Isoform Comparison

Biological Activity

Target
  • p110γ

    PI3Kγ, IC50:23 nM

  • p110β

    PI3Kβ, IC50:383 nM

  • p110α

    PI3Kα, IC50:39 nM

  • p110δ

    PI3Kδ, IC50:36 nM

  • p110β

    PI3Kβ, IC50:36 nM

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01943838 Neoplasm Malignant PHASE1 COMPLETED 2025-02-15 Investigational Site Number 05... More >>6001, Leuven, 3000, Belgium Less <<
NCT01392924 Neoplasm Malignant PHASE1 COMPLETED 2025-11-14 Investigational Site Number 39... More >>2002, Kobe-Shi, Japan|Investigational Site Number 392001, Nagoya-Shi, Japan Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.23mL

0.45mL

0.22mL

11.15mL

2.23mL

1.11mL

22.30mL

4.46mL

2.23mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories